CIK 0000875045 · Large accelerated filer
BIOGEN INC.
Sign in to watch- Ticker
- BIIB
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 330112644
- Phone
- 6176792000
- Business address
- 225 BINNEY STREET, CAMBRIDGE, MA, 02142
- Former names
- BIOGEN IDEC INC., BIOGEN IDEC INC, IDEC PHARMACEUTICALS CORP / DE, IDEC PHARMACEUTICALS CORP / CA
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-02-18 | Vounatsos Michel Chief Executive Officer | Grant or award · Restricted Stock Unit | +45,310 | 45,310 | ||
| 2021-02-18 | Sandrock Alfred EVP, Research & Development | Grant or award · Restricted Stock Unit | +14,500 | 14,500 | ||
| 2021-02-18 | MCDONNELL MICHAEL R EVP, Chief Financial Officer | Grant or award · Restricted Stock Unit | +14,500 | 14,500 | ||
| 2021-02-18 | Kramer Robin SVP, Chief Accounting Officer | Grant or award · Restricted Stock Unit | +2,900 | 2,900 | ||
| 2021-02-18 | Guindo Chirfi EVP Glob. Prod Strat and Comm | Grant or award · Restricted Stock Unit | +14,500 | 14,500 | ||
| 2021-02-18 | Gregory Ginger EVP, Human Resources | Grant or award · Restricted Stock Unit | +10,150 | 10,150 | ||
| 2021-02-18 | Galdes Alphonse EVP Pharmaceutical Oper & Tech | Grant or award · Restricted Stock Unit | +10,870 | 10,870 | ||
| 2021-02-18 | ALEXANDER SUSAN H EVP Chief Legal Off & Corp Sec | Grant or award · Restricted Stock Unit | +10,870 | 10,870 | ||
| 2021-02-12 | Vounatsos Michel Chief Executive Officer | Shares withheld for taxes | −7,248 | $278.03 | $2.0M | 43,905.29 |
| 2021-02-12 | Vounatsos Michel Chief Executive Officer | Option exercise | +5,693 | 49,598.29 | ||
| 2021-02-12 | Vounatsos Michel Chief Executive Officer | Option exercise | +5,259 | 54,857.29 | ||
| 2021-02-12 | Vounatsos Michel Chief Executive Officer | Option exercise | +5,337 | 60,194.29 | ||
| 2021-02-12 | Vounatsos Michel Chief Executive Officer | Shares withheld for taxes | −2,525 | $278.03 | $702K | 57,669.29 |
| 2021-02-12 | Vounatsos Michel Chief Executive Officer | Shares withheld for taxes | −2,333 | $278.03 | $649K | 55,336.29 |
| 2021-02-12 | Vounatsos Michel Chief Executive Officer | Shares withheld for taxes | −2,367 | $278.03 | $658K | 52,969.29 |
| 2021-02-12 | Vounatsos Michel Chief Executive Officer | Option exercise · Restricted Stock Unit | −5,693 | 6,419 | ||
| 2021-02-12 | Vounatsos Michel Chief Executive Officer | Other disposition · Restricted Stock Unit | −6,419 | 0 | ||
| 2021-02-12 | Vounatsos Michel Chief Executive Officer | Option exercise · Restricted Stock Unit | −5,259 | 19,789 | ||
| 2021-02-12 | Vounatsos Michel Chief Executive Officer | Other disposition · Restricted Stock Unit | −7,263 | 12,526 | ||
| 2021-02-12 | Vounatsos Michel Chief Executive Officer | Option exercise · Restricted Stock Unit | −5,337 | 32,343 |
Page 36 of 45 · 886 trades